Kestra Medical Technologies, Ltd. (KMTS)

Market Cap	1.25B
Revenue (ttm)	66.40M
Net Income (ttm)	-129.69M
Shares Out	51.45M
EPS (ttm)	-4.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	145,293
Open	24.23
Previous Close	24.12
Day's Range	24.14 - 24.72
52-Week Range	13.25 - 27.71
Beta	n/a
Analysts	Buy
Price Target	26.80 (+10.15%)
Earnings Date	Sep 11, 2025

About KMTS

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardiovert...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 6, 2025
• Employees: 330
• Stock Exchange: NASDAQ
• Ticker Symbol: KMTS
• Website: https://kestramedical.com

Financial Performance

In 2025, KMTS's revenue was $59.82 million, an increase of 115.05% compared to the previous year's $27.81 million. Losses were -$126.14 million, 25.1% more than in 2024.

Analyst Forecast

According to 5 analysts, the average rating for KMTS stock is "Buy." The 12-month stock price target is $26.8, which is an increase of 10.15% from the latest price.

Price Target

$26.8

(10.15% upside)

Analyst Consensus: Buy